J A Kemp is one of Europe’s leading filers of patent applications relating to cell and gene therapies. In this webinar, partners Lucy Barnes and Lucy Williams will draw on their extensive experience in this field to explore strategies for securing effective patent protection for cell and gene therapies.

They will consider how patent strategy can support investment and licensing, strengthen competitive position, and help build commercially valuable protection around both therapeutic products and platform technologies.

Topics include:
What value can patents provide? How can patent protection support the commercial development of cell and gene therapies?
What can be patented? Which claim categories are most useful, what scope of protection may be available, and to what extent can platform technologies be protected?
When should you file? How much data is needed, and how well defined does the product need to be?
Where should you file? How important is broad geographic protection, and what should influence filing strategy?
What about freedom to operate? Including the potential relevance of supplementary protection certificates and equivalents.
Who should attend?
This webinar is relevant to anyone looking to deepen their understanding of patenting in the cell and gene therapy sector.

Whether you are an executive or legal professional at a small or medium-sized cell and gene therapy enterprise, in-house patent or other legal counsel at a pharmaceutical company working on cell and gene therapy products, or a private practice patent attorney working in the cell and gene therapy field, the webinar will provide practical insights and perspectives relevant to your work.

Live webinar and Q&A
This is a live webinar, and attendees will have the opportunity to put questions directly to Lucy Barnes and Lucy Williams during the Q&A session.